CCR2+ monocytes are dispensable to resolve acute pulmonary Pseudomonas aeruginosa infections in WT and cystic fibrosis mice
Journal of Leukocyte Biology · 2025
DOI: 10.1093/jleuko/qiae218 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2025. Verfasst von Hasan H Öz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pediatrics, Yale School of Medicine, 333 Cedar St, New Haven, CT 06510, United States. Hauptthemen laut MEDLINE: Pseudomonas Infections, Receptors, CCR2, Monocytes, Pseudomonas aeruginosa. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Extravasation of CCR2-positive monocytes into tissue and to the site of injury is a fundamental immunological response to infections. Nevertheless, exuberant recruitment and/or activity of these monocytes and monocyte-derived macrophages can propagate tissue damage, especially in chronic inflammatory disease conditions. We have previously shown that inhibiting the recruitment of CCR2-positive monocytes ameliorates lung tissue damage caused by chronic neutrophilic inflammation in cystic fibrosis mouse models. A potential concern with targeting monocyte recruitment for therapeutic benefit in cystic fibrosis, however, is whether they are essential for eradicating infections such as Pseudomonas aeruginosa, a pathogen that commonly colonizes and damages the lungs of patients with cystic fibrosis. In this study, we investigated the role of CCR2-positive monocytes in the immune response to acute pulmonary P. aeruginosa infection. Our data show that the altered host immune response caused by the lack of monocyte recruitment to the lungs does not impact P. aeruginosa lung colonization, clearance, and the severity of the infection. These results also hold up in a cystic fibrosis mouse background, which has a hyperinflammatory immune response yet exhibits reduced bactericidal activity. Thus, we lay the groundwork for future studies to investigate the use of CCR2 inhibitors as a potential therapy to ameliorate lung tissue damage in cystic fibrosis. This could be given alone or as an adjunct therapy with CFTR modulators that significantly improve clinical outcomes for eligible patients but do not completely resolve the persistent infection and inflammation that drive lung tissue damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Pediatrics, Yale School of Medicine, 333 Cedar St, New Haven, CT 06510, United States.
- Departments of Laboratory Medicine, Yale School of Medicine, 333 Cedar St, New Haven, CT 06510, United States.
- Departments of Cell Biology, Yale School of Medicine, 333 Cedar St, New Haven, CT 06510, United States.
- Departments of Cellular and Molecular Physiology, Yale School of Medicine, 333 Cedar St, New Haven, CT 06510, United States.
ORCID-Profile: Hasan H Öz, Emanuela M Bruscia
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- NIDDK NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Öz, H. H., Braga, C. L., Gudneppanavar, R., Di Pietro, C., Huang, P. H., Zhang, P. X., Krause, D. S., Egan, M. E., Murray, T. S., & Bruscia, E. M. (2025). CCR2+ monocytes are dispensable to resolve acute pulmonary Pseudomonas aeruginosa infections in WT and cystic fibrosis mice. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiae218
Vancouver
Öz HH, Braga CL, Gudneppanavar R, Di Pietro C, Huang PH, Zhang PX, et al. CCR2+ monocytes are dispensable to resolve acute pulmonary Pseudomonas aeruginosa infections in WT and cystic fibrosis mice. Journal of Leukocyte Biology. 2025. doi:10.1093/jleuko/qiae218
BibTeX
@article{z2025,
author = {Öz, Hasan H and Braga, Cassia L and Gudneppanavar, Ravindra and Di Pietro, Caterina and Huang, Pamela H and Zhang, Ping-Xia and Krause, Diane S and Egan, Marie E and Murray, Thomas S and Bruscia, Emanuela M},
title = {CCR2+ monocytes are dispensable to resolve acute pulmonary Pseudomonas aeruginosa infections in WT and cystic fibrosis mice},
journal = {Journal of Leukocyte Biology},
year = {2025},
doi = {10.1093/jleuko/qiae218}
}
EUVIMED